Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M G Matera

Showing results (71-80 of 113) with videos related to

Pageof 12
Sort By:
Pulmonary Pharmacology|December 1, 1995
A comparison of the bronchodilating effects of salmeterol, salbutamol and ipratropium bromide in patients with chronic obstructive pulmonary diseaseM G Matera, M Cazzola, A Vinciguerra, et al.
Pulmonary Pharmacology & Therapeutics|May 5, 2004
Onset of action of formoterol/budesonide in single inhaler vs. formoterol in patients with COPDM Cazzola, P Santus, F Di Marco, et al.
The European Respiratory Journal|July 10, 1998
Effects of formoterol, salmeterol or oxitropium bromide on airway responses to salbutamol in COPDM Cazzola, F Di Perna, P Noschese, et al.
Respiratory Medicine|May 9, 2003
A single high dose of formoterol is as effective as the same dose administered in a cumulative manner in patients with acute exacerbation of COPDM Cazzola, P Santus, M G Matera, et al.
Immunopharmacology|February 1, 1995
Role of 5-hydroxytryptamine in mediating adenosine-induced airway contractionM G Matera, D De Santis, B D'Agostino, et al.
Chest|September 3, 1998
Cardiac effects of formoterol and salmeterol in patients suffering from COPD with preexisting cardiac arrhythmias and hypoxemiaM Cazzola, F Imperatore, A Salzillo, et al.
Clinical Therapeutics|May 23, 2002
Formoterol as dry powder oral inhalation compared with salbutamol metered-dose inhaler in acute exacerbations of chronic obstructive pulmonary diseaseM Cazzola, M D'Amato, C Califano, et al.
Respiratory Medicine|July 16, 2002
Addition of an extra dose of salmeterol Diskus to conventional dose of salmeterol Diskus in patients with COPDM Cazzola, P Santus, F Castagna, et al.
European Journal of Clinical Pharmacology|February 23, 1999
Oral bambuterol compared to inhaled salmeterol in patients with partially reversible chronic obstructive pulmonary diseaseM Cazzola, F Calderaro, C Califano, et al.
Journal of Veterinary Pharmacology and Therapeutics|March 28, 2018
Combining long-acting bronchodilators with different mechanisms of action: A pharmacological approach to optimize bronchodilation of equine airwaysL Calzetta, P Rogliani, E Pistocchini, et al.
Pageof 12

Showing results (71-80 of 113) with videos related to

Sort By:
Pageof 12
Pulmonary Pharmacology|December 1, 1995
A comparison of the bronchodilating effects of salmeterol, salbutamol and ipratropium bromide in patients with chronic obstructive pulmonary diseaseM G Matera, M Cazzola, A Vinciguerra, et al.
Pulmonary Pharmacology & Therapeutics|May 5, 2004
Onset of action of formoterol/budesonide in single inhaler vs. formoterol in patients with COPDM Cazzola, P Santus, F Di Marco, et al.
The European Respiratory Journal|July 10, 1998
Effects of formoterol, salmeterol or oxitropium bromide on airway responses to salbutamol in COPDM Cazzola, F Di Perna, P Noschese, et al.
Respiratory Medicine|May 9, 2003
A single high dose of formoterol is as effective as the same dose administered in a cumulative manner in patients with acute exacerbation of COPDM Cazzola, P Santus, M G Matera, et al.
Immunopharmacology|February 1, 1995
Role of 5-hydroxytryptamine in mediating adenosine-induced airway contractionM G Matera, D De Santis, B D'Agostino, et al.
Chest|September 3, 1998
Cardiac effects of formoterol and salmeterol in patients suffering from COPD with preexisting cardiac arrhythmias and hypoxemiaM Cazzola, F Imperatore, A Salzillo, et al.
Clinical Therapeutics|May 23, 2002
Formoterol as dry powder oral inhalation compared with salbutamol metered-dose inhaler in acute exacerbations of chronic obstructive pulmonary diseaseM Cazzola, M D'Amato, C Califano, et al.
Respiratory Medicine|July 16, 2002
Addition of an extra dose of salmeterol Diskus to conventional dose of salmeterol Diskus in patients with COPDM Cazzola, P Santus, F Castagna, et al.
European Journal of Clinical Pharmacology|February 23, 1999
Oral bambuterol compared to inhaled salmeterol in patients with partially reversible chronic obstructive pulmonary diseaseM Cazzola, F Calderaro, C Califano, et al.
Journal of Veterinary Pharmacology and Therapeutics|March 28, 2018
Combining long-acting bronchodilators with different mechanisms of action: A pharmacological approach to optimize bronchodilation of equine airwaysL Calzetta, P Rogliani, E Pistocchini, et al.
Pageof 12